We are live on
!
Find out more
OA
Oak Associates Portfolio holdings
AUM
$1.49B
1-Year Est. Return
34.25%
This Fund
S&P 500
This Quarter
Est. Return
+0.21%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.2B
AUM Growth
-$48.8M
(-3.9%)
Cap. Flow
-$39.7M
Cap. Flow
% of AUM
-3.3%
Top 10 Holdings %
Top 10 Hldgs %
45.64%
Holding
136
New
5
Increased
35
Reduced
40
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$2.35M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$2.02M |
| 3 |
Cigna
CI
|
+$1.29M |
| 4 |
Progyny
PGNY
|
+$845K |
| 5 |
Korn Ferry
KFY
|
+$627K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$20M |
| 2 |
Amazon
AMZN
|
+$11.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$3.35M |
| 4 |
Labcorp
LH
|
+$2.27M |
| 5 |
PepsiCo
PEP
|
+$2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.34% |
| 2 | Healthcare | 15.66% |
| 3 | Communication Services | 15.45% |
| 4 | Consumer Discretionary | 10.79% |
| 5 | Financials | 10.54% |
Similar funds
FAT
AIA
LFS
PIM
NAM
RIM
SB
MHS
Oak Associates's Q3 2023 Portfolio in Review
As of Q3 2023, Oak Associates held 136 positions worth $1.2B, down 3.9% from $1.25B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Oak Associates withdrew a net $39.7M in Q3 2023, closing 3 positions and reducing 40 holdings. Its most notable exit was AbbVie, an estimated $2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 44% of assets, down from 46% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Oak Associates opened a new position in Thermo Fisher Scientific worth $1.92M.
- Oak Associates's largest Q3 2023 buy was Thermo Fisher Scientific: 3,791 shares worth $1.92M.
- Oak Associates added most to PayPal in Q3 2023, an estimated $2.35M increase.
- Oak Associates's biggest Q3 2023 reduction was Apple, cutting an estimated $20M.
- Oak Associates fully exited AbbVie in Q3 2023, selling an estimated $2M.
- Oak Associates's ten largest holdings make up 46% of its $1.2B portfolio in Q3 2023.
- Oak Associates opened 5 new positions and closed 3 in Q3 2023.
- Oak Associates's portfolio value fell 3.9% quarter-over-quarter to $1.2B.
Based on Oak Associates's 13F filing for Q3 2023, filed 13 Nov 2023.